Mediclinic International PLC (LON: MDC) has recently received a number of price target changes and ratings updates:

  • 10/27/2017 – Mediclinic International PLC had its “underperform” rating reaffirmed by analysts at Jefferies Group LLC. They now have a GBX 550 ($7.26) price target on the stock.
  • 10/26/2017 – Mediclinic International PLC had its price target raised by analysts at Credit Suisse Group from GBX 265 ($3.50) to GBX 305 ($4.02). They now have a “neutral” rating on the stock.
  • 10/26/2017 – Mediclinic International PLC had its “neutral” rating reaffirmed by analysts at Macquarie. They now have a GBX 660 ($8.71) price target on the stock.
  • 10/24/2017 – Mediclinic International PLC had its “neutral” rating reaffirmed by analysts at Citigroup Inc..
  • 10/20/2017 – Mediclinic International PLC had its price target lowered by analysts at Macquarie from GBX 760 ($10.03) to GBX 660 ($8.71). They now have a “neutral” rating on the stock.
  • 10/19/2017 – Mediclinic International PLC was downgraded by analysts at J P Morgan Chase & Co to a “neutral” rating. They now have a GBX 733 ($9.67) price target on the stock, down previously from GBX 898 ($11.85).
  • 10/18/2017 – Mediclinic International PLC had its price target lowered by analysts at Citigroup Inc. from GBX 790 ($10.42) to GBX 720 ($9.50). They now have a “neutral” rating on the stock.
  • 9/25/2017 – Mediclinic International PLC had its price target lowered by analysts at Jefferies Group LLC from GBX 650 ($8.58) to GBX 550 ($7.26). They now have an “underperform” rating on the stock.

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.